Loading…

Transoral laser microsurgery for untreated glottic carcinoma

To report the oncology and functional outcomes of transoral laser microsurgery (TLM) for untreated glottic carcinoma. A 2 center prospective case series analysis. Academic, tertiary referral centers. Seventy-six patients underwent TLM. Pathologic T stages were: T1, 45 (59%); T2, 21 (28%); T3, 5 (7%)...

Full description

Saved in:
Bibliographic Details
Published in:Otolaryngology-head and neck surgery 2007-09, Vol.137 (3), p.482-486
Main Authors: Grant, David G., Salassa, John R., Hinni, Michael L., Pearson, Bruce W., Hayden, Richard E., Perry, William C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753
cites cdi_FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753
container_end_page 486
container_issue 3
container_start_page 482
container_title Otolaryngology-head and neck surgery
container_volume 137
creator Grant, David G.
Salassa, John R.
Hinni, Michael L.
Pearson, Bruce W.
Hayden, Richard E.
Perry, William C.
description To report the oncology and functional outcomes of transoral laser microsurgery (TLM) for untreated glottic carcinoma. A 2 center prospective case series analysis. Academic, tertiary referral centers. Seventy-six patients underwent TLM. Pathologic T stages were: T1, 45 (59%); T2, 21 (28%); T3, 5 (7%); and T4, 5 (7%). Five (7%) patients had neck dissections. Five (7%) patients received adjuvant radiotherapy. Mean follow-up was 42 months. Respective T1 and T2 5-year Kaplan-Meier estimates were: local control, 90% and 93%; loco-regional control, 90% and 93%; disease specific survival, 90% and 93%; and overall survival, 94% and 93%. The average hospital stay was 2 days. Two (3%) patients experienced major complications. The overall laryngeal preservation rate was 95% (72 of 76). TLM is a safe and effective treatment in select carcinoma of the glottic larynx. Low morbidity and mortality and short periods of hospitalization make TLM an attractive therapeutic option. TLM is an emerging strategy in the treatment of laryngeal cancer.
doi_str_mv 10.1016/j.otohns.2007.05.064
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68234402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1016_j.otohns.2007.05.064</sage_id><els_id>S0194599807006444</els_id><sourcerecordid>68234402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753</originalsourceid><addsrcrecordid>eNqNkEtv1DAURi1URKeFf4BQVt0lvU78ilQhwagPpIpuytry2NeDR0lc7KRo_j2ZZiR2hZU33zm6PoR8pFBRoOJyV8Ux_hxyVQPICngFgr0hKwqtLIWi8oSsgLas5G2rTslZzjsAEELKd-SUSim4VLAiV4_JDDkm0xWdyZiKPtgU85S2mPaFj6mYhjGhGdEV2y6OY7CFNcmGIfbmPXnrTZfxw_E9Jz9urh_Xd-X9w-239Zf70jLOoWSNrKVxfMOcYd5tqLGSco-euoZ5BHBe1XzjpaIUG-Ws8k61LRPCi8ZL3pyTi8X7lOKvCfOo-5Atdp0ZME5ZC1U3jEE9D9kyPPwhJ_T6KYXepL2moA_V9E4v1fShmgau52oz9unonzY9ur_QMdM8uFoGv0OH-_-S6oe7719vamhfcLrg2WxR7-KUhjnXv276vDA4h30OmHS2AQeLLiS0o3YxvC74A4qdpBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68234402</pqid></control><display><type>article</type><title>Transoral laser microsurgery for untreated glottic carcinoma</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Grant, David G. ; Salassa, John R. ; Hinni, Michael L. ; Pearson, Bruce W. ; Hayden, Richard E. ; Perry, William C.</creator><creatorcontrib>Grant, David G. ; Salassa, John R. ; Hinni, Michael L. ; Pearson, Bruce W. ; Hayden, Richard E. ; Perry, William C.</creatorcontrib><description>To report the oncology and functional outcomes of transoral laser microsurgery (TLM) for untreated glottic carcinoma. A 2 center prospective case series analysis. Academic, tertiary referral centers. Seventy-six patients underwent TLM. Pathologic T stages were: T1, 45 (59%); T2, 21 (28%); T3, 5 (7%); and T4, 5 (7%). Five (7%) patients had neck dissections. Five (7%) patients received adjuvant radiotherapy. Mean follow-up was 42 months. Respective T1 and T2 5-year Kaplan-Meier estimates were: local control, 90% and 93%; loco-regional control, 90% and 93%; disease specific survival, 90% and 93%; and overall survival, 94% and 93%. The average hospital stay was 2 days. Two (3%) patients experienced major complications. The overall laryngeal preservation rate was 95% (72 of 76). TLM is a safe and effective treatment in select carcinoma of the glottic larynx. Low morbidity and mortality and short periods of hospitalization make TLM an attractive therapeutic option. TLM is an emerging strategy in the treatment of laryngeal cancer.</description><identifier>ISSN: 0194-5998</identifier><identifier>EISSN: 1097-6817</identifier><identifier>DOI: 10.1016/j.otohns.2007.05.064</identifier><identifier>PMID: 17765780</identifier><language>eng</language><publisher>Los Angeles, CA: Mosby, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Cohort Studies ; Databases, Factual ; Female ; Glottis ; Humans ; Laryngeal Neoplasms - pathology ; Laryngeal Neoplasms - surgery ; Laser Therapy ; Male ; Microsurgery ; Middle Aged ; Mouth ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Otolaryngology-head and neck surgery, 2007-09, Vol.137 (3), p.482-486</ispartof><rights>2007 American Academy of Otolaryngology–Head and Neck Surgery Foundation</rights><rights>2007 SAGE Publications</rights><rights>2007 American Association of Otolaryngology‐Head and Neck Surgery Foundation (AAO‐HNSF)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753</citedby><cites>FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17765780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grant, David G.</creatorcontrib><creatorcontrib>Salassa, John R.</creatorcontrib><creatorcontrib>Hinni, Michael L.</creatorcontrib><creatorcontrib>Pearson, Bruce W.</creatorcontrib><creatorcontrib>Hayden, Richard E.</creatorcontrib><creatorcontrib>Perry, William C.</creatorcontrib><title>Transoral laser microsurgery for untreated glottic carcinoma</title><title>Otolaryngology-head and neck surgery</title><addtitle>Otolaryngol Head Neck Surg</addtitle><description>To report the oncology and functional outcomes of transoral laser microsurgery (TLM) for untreated glottic carcinoma. A 2 center prospective case series analysis. Academic, tertiary referral centers. Seventy-six patients underwent TLM. Pathologic T stages were: T1, 45 (59%); T2, 21 (28%); T3, 5 (7%); and T4, 5 (7%). Five (7%) patients had neck dissections. Five (7%) patients received adjuvant radiotherapy. Mean follow-up was 42 months. Respective T1 and T2 5-year Kaplan-Meier estimates were: local control, 90% and 93%; loco-regional control, 90% and 93%; disease specific survival, 90% and 93%; and overall survival, 94% and 93%. The average hospital stay was 2 days. Two (3%) patients experienced major complications. The overall laryngeal preservation rate was 95% (72 of 76). TLM is a safe and effective treatment in select carcinoma of the glottic larynx. Low morbidity and mortality and short periods of hospitalization make TLM an attractive therapeutic option. TLM is an emerging strategy in the treatment of laryngeal cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Cohort Studies</subject><subject>Databases, Factual</subject><subject>Female</subject><subject>Glottis</subject><subject>Humans</subject><subject>Laryngeal Neoplasms - pathology</subject><subject>Laryngeal Neoplasms - surgery</subject><subject>Laser Therapy</subject><subject>Male</subject><subject>Microsurgery</subject><subject>Middle Aged</subject><subject>Mouth</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0194-5998</issn><issn>1097-6817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkEtv1DAURi1URKeFf4BQVt0lvU78ilQhwagPpIpuytry2NeDR0lc7KRo_j2ZZiR2hZU33zm6PoR8pFBRoOJyV8Ux_hxyVQPICngFgr0hKwqtLIWi8oSsgLas5G2rTslZzjsAEELKd-SUSim4VLAiV4_JDDkm0xWdyZiKPtgU85S2mPaFj6mYhjGhGdEV2y6OY7CFNcmGIfbmPXnrTZfxw_E9Jz9urh_Xd-X9w-239Zf70jLOoWSNrKVxfMOcYd5tqLGSco-euoZ5BHBe1XzjpaIUG-Ws8k61LRPCi8ZL3pyTi8X7lOKvCfOo-5Atdp0ZME5ZC1U3jEE9D9kyPPwhJ_T6KYXepL2moA_V9E4v1fShmgau52oz9unonzY9ur_QMdM8uFoGv0OH-_-S6oe7719vamhfcLrg2WxR7-KUhjnXv276vDA4h30OmHS2AQeLLiS0o3YxvC74A4qdpBI</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Grant, David G.</creator><creator>Salassa, John R.</creator><creator>Hinni, Michael L.</creator><creator>Pearson, Bruce W.</creator><creator>Hayden, Richard E.</creator><creator>Perry, William C.</creator><general>Mosby, Inc</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200709</creationdate><title>Transoral laser microsurgery for untreated glottic carcinoma</title><author>Grant, David G. ; Salassa, John R. ; Hinni, Michael L. ; Pearson, Bruce W. ; Hayden, Richard E. ; Perry, William C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Cohort Studies</topic><topic>Databases, Factual</topic><topic>Female</topic><topic>Glottis</topic><topic>Humans</topic><topic>Laryngeal Neoplasms - pathology</topic><topic>Laryngeal Neoplasms - surgery</topic><topic>Laser Therapy</topic><topic>Male</topic><topic>Microsurgery</topic><topic>Middle Aged</topic><topic>Mouth</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grant, David G.</creatorcontrib><creatorcontrib>Salassa, John R.</creatorcontrib><creatorcontrib>Hinni, Michael L.</creatorcontrib><creatorcontrib>Pearson, Bruce W.</creatorcontrib><creatorcontrib>Hayden, Richard E.</creatorcontrib><creatorcontrib>Perry, William C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Otolaryngology-head and neck surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grant, David G.</au><au>Salassa, John R.</au><au>Hinni, Michael L.</au><au>Pearson, Bruce W.</au><au>Hayden, Richard E.</au><au>Perry, William C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transoral laser microsurgery for untreated glottic carcinoma</atitle><jtitle>Otolaryngology-head and neck surgery</jtitle><addtitle>Otolaryngol Head Neck Surg</addtitle><date>2007-09</date><risdate>2007</risdate><volume>137</volume><issue>3</issue><spage>482</spage><epage>486</epage><pages>482-486</pages><issn>0194-5998</issn><eissn>1097-6817</eissn><abstract>To report the oncology and functional outcomes of transoral laser microsurgery (TLM) for untreated glottic carcinoma. A 2 center prospective case series analysis. Academic, tertiary referral centers. Seventy-six patients underwent TLM. Pathologic T stages were: T1, 45 (59%); T2, 21 (28%); T3, 5 (7%); and T4, 5 (7%). Five (7%) patients had neck dissections. Five (7%) patients received adjuvant radiotherapy. Mean follow-up was 42 months. Respective T1 and T2 5-year Kaplan-Meier estimates were: local control, 90% and 93%; loco-regional control, 90% and 93%; disease specific survival, 90% and 93%; and overall survival, 94% and 93%. The average hospital stay was 2 days. Two (3%) patients experienced major complications. The overall laryngeal preservation rate was 95% (72 of 76). TLM is a safe and effective treatment in select carcinoma of the glottic larynx. Low morbidity and mortality and short periods of hospitalization make TLM an attractive therapeutic option. TLM is an emerging strategy in the treatment of laryngeal cancer.</abstract><cop>Los Angeles, CA</cop><pub>Mosby, Inc</pub><pmid>17765780</pmid><doi>10.1016/j.otohns.2007.05.064</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0194-5998
ispartof Otolaryngology-head and neck surgery, 2007-09, Vol.137 (3), p.482-486
issn 0194-5998
1097-6817
language eng
recordid cdi_proquest_miscellaneous_68234402
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Cohort Studies
Databases, Factual
Female
Glottis
Humans
Laryngeal Neoplasms - pathology
Laryngeal Neoplasms - surgery
Laser Therapy
Male
Microsurgery
Middle Aged
Mouth
Retrospective Studies
Treatment Outcome
title Transoral laser microsurgery for untreated glottic carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A47%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transoral%20laser%20microsurgery%20for%20untreated%20glottic%20carcinoma&rft.jtitle=Otolaryngology-head%20and%20neck%20surgery&rft.au=Grant,%20David%20G.&rft.date=2007-09&rft.volume=137&rft.issue=3&rft.spage=482&rft.epage=486&rft.pages=482-486&rft.issn=0194-5998&rft.eissn=1097-6817&rft_id=info:doi/10.1016/j.otohns.2007.05.064&rft_dat=%3Cproquest_cross%3E68234402%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4550-43727ad5b4da4fdb1ac715fef1d34fe00df825bf7811e38dc8fd899466f63f753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68234402&rft_id=info:pmid/17765780&rft_sage_id=10.1016_j.otohns.2007.05.064&rfr_iscdi=true